CDK6 and cervical carcinoma: This may explain why overexpressing IL1A could not fully rescue the proliferation inhibiting effect caused by knocking down p16: after knocking down p16, CDK6 got a relief from suppression, which then could use not only kinase activity but also transcriptional regulatory ability to synergistically inhibit proliferation of cervical cancer cells.